Micofenolato de mofetilo en nefritis lúpica refractaria a ciclofosfamida intravenosa

MMF doses of 1.5-2 grams per day are a good alternative in LN patients without response to intravenous cyclophosphamide and a low chronicity index. No severe adverse effects were found.